← Eichor
Study identifier: NCT04588402 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

Condition: Cervical Cancer  ·  Sponsor: International Agency for Research on Cancer

PhaseN/A
Planned participants5500
Who can joinFemale, 18 Years to 22 Years
Healthy volunteersYes

About this study

This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.

This description comes directly from the study's public registry record.

Talk to the study team

Partha Basu, MD, PhD  ·  +33 472 738 167  ·  basup@iarc.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Sikkim Manipal HospitalGangtok, Sikkim, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04588402